NICE clarifies diagnosis and management of prostate cancer and advises on smoking cessationBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39504.480752.DB (Published 28 February 2008) Cite this as: BMJ 2008;336:471
- Susan Mayor
Men with low risk, localised prostate cancer should be offered active surveillance before radical treatment options, recommends a guideline for the NHS in England and Wales published this week. The guideline, developed by the National Institute for Health and Clinical Excellence (NICE), aims to clarify how best to diagnose and treat the disease, based on developments in the past few years.
The guideline notes that although prostate cancer is one of the most common cancers in men it can be slow growing and may not affect general health for many years.
John Graham, consultant clinical oncologist at Taunton and Somerset NHS Trust …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial